Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.
about
HLA-B27 and psoriatic disease: a modern view of an old relationshipHLA-B27 misfolding and ankylosing spondylitisHLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic RatsHLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic ratsFrom HLA-B27 to spondyloarthritis: a journey through the ER.Autoimmune epididymoorchitis is essential to the pathogenesis of male-specific spondylarthritis in HLA-B27-transgenic ratsData showing non-conventional HLA-B27 expression in axial joints and gut tissue from B27 transgenic rats, and in frozen and paraffin-fixed synovial SpA tissue.Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors.Predicting important residues and interaction pathways in proteins using Gaussian Network Model: binding and stability of HLA proteins.The genetic basis of ankylosing spondylitis: new insights into disease pathogenesisHLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats.Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitisPathogenicity of Misfolded and Dimeric HLA-B27 MoleculesAnkylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response.Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression.Mechanisms of Disease: the immunopathogenesis of spondyloarthropathies.Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy.Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitorsNon-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue.Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis.HLA-B27 misfolding and spondyloarthropathies.Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease?Endoplasmic reticulum stress and intestinal inflammation.Joint involvement in inflammatory bowel disease: managing inflammation outside the digestive system.Role of HLA-B27 in the pathogenesis of ankylosing spondylitis (Review).Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.Review: animal models as a tool to dissect pivotal pathways driving spondyloarthritis.Innate Immune Activation Can Trigger Experimental Spondyloarthritis in HLA-B27/Huβ2m Transgenic Rats.The role of the unfolded protein response in axial spondyloarthritis.Pathogenesis of ligaments ossification in spondyloarthritis: insights and doubts.Autoinflammation and HLA-B27: Beyond Antigen Presentation.Lessons to be learned from serum biomarkers in psoriasis and IBD - the potential role in SpA.No evidence for a direct role of HLA-B27 in pathological bone formation in axial SpA.Mutational analysis reveals a complex interplay of peptide binding and multiple biological features of HLA-B27.TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats.Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies.HLA-B27 subtype oligomerization and intracellular accumulation patterns correlate with predisposition to spondyloarthritis.Relationship between inflammation, bone destruction, and osteoproliferation in the HLA-B27/human β2 -microglobulin-transgenic rat model of spondylarthritis.Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α.
P2860
Q26796433-EEF66BF7-C26C-4839-A51A-E3EFA50FEB10Q26860818-6F938D33-2B03-466C-9456-EAF7F586F9BCQ27303777-A982919E-D2A0-497F-84C0-D6D5F2A9F92EQ27313830-21697956-9128-48D8-B8E9-19910A948C85Q27687662-FA1A36B8-3C66-43B5-896B-688DC19DE519Q30417834-B8363797-49BE-497B-8F04-F3A464BB8425Q31131617-92B9C44D-E6C2-4B23-8DCC-BF1B254ACB89Q33624763-3BB89EB9-058D-46B1-ABCE-B054E3A938F7Q33632284-AACB50FB-CDCA-4034-B4E3-D12B28931F25Q33806334-B29EA1F6-9844-49E4-B220-52C3CCFA8023Q33945978-1C60E827-B494-4881-9994-562B646475FAQ34345584-DC28F845-AD1F-4A88-B53D-C08E31328A7EQ34921584-AD3319A1-46D4-4565-8E80-B211C19C6C77Q35585432-6BDE6F1B-32CF-4BA4-86CE-FB58556EDDC8Q35854185-655D3FFE-0C22-4CA5-BBA6-0CC6DE9A23FCQ36577527-3BB98C86-0DC5-4D13-9699-C768FB68F085Q36760435-78370D01-441B-4DBD-9C6A-F1E2E3A66D57Q36907665-126C637D-C0B4-4DC5-8C37-A2C27F4D6DA9Q36913820-B2262696-6614-44F1-8D81-038A2DD608B6Q37167616-EC5E99B7-FB37-4D62-9AA7-858416ECE594Q37178385-1EF0C309-D5B9-42B7-A750-7A8525DECE19Q37547278-6ACFB8DE-09ED-4751-84C7-B4FD7B11CEE4Q37623437-A60A0ECF-F775-4D61-9A99-D57847650781Q37688137-16B9681C-C3A0-4892-A42E-AF4F8571B04EQ37720215-AA3B23CD-8C13-4097-9978-89100A4E88C5Q38071564-659DD219-BD34-4F33-9A97-15803FAE41DEQ38380973-F7ED1357-7368-4892-A040-402702A5E4A1Q38555291-984A2C8C-DF42-4C44-AD4F-2E84FACD3FF2Q38616684-996F7BB6-7B85-4200-8692-84460D173247Q38633365-FC9AEC2E-BBC5-433B-8057-D0B99B50458AQ38816459-AC8EF659-373E-46E7-A0A9-52DC38896060Q38845301-15859FAC-6199-438A-A26C-F9BB9423B47BQ38972679-0FCF0A0B-A428-437D-92DC-F7E88B98C8F3Q40063353-92D44E44-4039-4512-868B-CD102ADC4883Q41176761-8C3AC2AE-5450-4D2F-B93C-58566B46731EQ41861964-717CB8D5-B846-44D9-A2DC-C2B728CDCB40Q42126037-B4D77EF7-D2F6-40D5-9D43-25A6D7D3099BQ42221004-1941485A-6B7F-43C8-9FD8-E4193344F370Q42534690-02CF5B5F-C91E-43C4-B285-624BEBD6A596Q42914686-02A348F2-A275-42AB-9D02-20130F9034C4
P2860
Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Additional human beta2-microgl ...... male HLA-B27-transgenic rats.
@en
Additional human beta2-microgl ...... male HLA-B27-transgenic rats.
@nl
type
label
Additional human beta2-microgl ...... male HLA-B27-transgenic rats.
@en
Additional human beta2-microgl ...... male HLA-B27-transgenic rats.
@nl
prefLabel
Additional human beta2-microgl ...... male HLA-B27-transgenic rats.
@en
Additional human beta2-microgl ...... male HLA-B27-transgenic rats.
@nl
P2093
P2860
P356
P1476
Additional human beta2-microgl ...... male HLA-B27-transgenic rats.
@en
P2093
James A Richardson
Joel D Taurog
Martha L Dorris
Nimman Satumtira
Robert E Hammer
Tri M Tran
P2860
P304
P356
10.1002/ART.21740
P577
2006-04-01T00:00:00Z